Agenda of the Extraordinary CHMP meeting 26 September 2024

Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 26 September 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 September 2024, 10:00 (CEST) to 26 September 2024, 13:00 (CEST)

Superseded community herbal monograph on Rosmarinus officinalis L., folium

List of centrally authorised products with safety-related changes to the product information

Human medicines European public assessment report (EPAR): Giapreza, angiotensin II, Date of authorisation: 23/08/2019, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Status: Authorised

List of eligible industry stakeholder organisations

CTIS newsflash - 24 September 2024

Template for letter from marketing-authorisation holder (MAH) permitting the Agency to send certificates elsewhere than to MAH address

List of European Union reference dates and frequency of submission of periodic safety update reports (PSURs)